Nautilus Biotechnology Revenue and Competitors

San Carlos,

Location

$303.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nautilus Biotechnology's estimated annual revenue is currently $20.3M per year.(i)
  • Nautilus Biotechnology's estimated revenue per employee is $122,319
  • Nautilus Biotechnology's total funding is $303.2M.
  • Nautilus Biotechnology's current valuation is $550.1M. (January 2022)

Employee Data

  • Nautilus Biotechnology has 166 Employees.(i)
  • Nautilus Biotechnology grew their employee count by 38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$15.3M99-49%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.5M29-6%N/AN/A
#10
$9.6M62-7%N/AN/A
Add Company

Born from the foundersᅢᄁ¬ツᆲ¬トᄁ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

keywords:N/A

$303.2M

Total Funding

166

Number of Employees

$20.3M

Revenue (est)

38%

Employee Growth %

$550.1M

Valuation

N/A

Accelerator

Nautilus Biotechnology News

2022-04-19 - Nautilus Biotechnology (NAUT) Set to Announce Earnings on ...

Analysts expect Nautilus Biotechnology to post earnings of ($0.15) per share for the quarter. Persons that are interested in registering for the...

2022-03-30 - Nautilus Biotechnology to Present at EuPA and AACR Meetings

About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco...

2022-03-22 - Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to ...

About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco...

2021-02-08 - Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. (Nautilus Photo) Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC. The deal, announced M ...

2021-02-08 - Nautilus Bio lines up SPAC merger and $350M in funding for proteomics R&D

Seattle-based Nautilus is combining with Arya III, a special purpose acquisition company (SPAC), which is a publicly traded entity formed as a vehicle for other companies to go public. The combined company, which will be run by Nautilus’s management, will have a valuation of about $900 million. ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A171-4%N/A
#2
$15M19565%N/A
#3
$62.5M1968%N/A
#4
$31.6M20444%N/A
#5
$34.8M223-26%$173.2M